Department of Cancer Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Cancer Med. 2021 May;10(10):3449-3460. doi: 10.1002/cam4.3857. Epub 2021 May 2.
Risk factors of cervical cancer (CC) development are well investigated, however, those influencing the risk of a potential false negative cytology preceding diagnosis of an invasive CC are not. We have aimed to explore these factors according to the data from Organised Cervical Cancer Screening Programme (OCCSP) in Poland. A total of 2.36 million of Pap tests sampled in 2010-2012 within OCCSP were merged with the Polish National Cancer Registry to identify CC cases after abnormal cytology and after normal cytology within 3 years of screening. Of 1460 invasive CCs, 1025 were preceded by abnormal and 399 by normal cytology result. Multivariate logistic analysis indicated that the presence of microorganisms in the Pap (OR = 2.18, 95% CI 1.65-2.87), evaluation by smaller (below 9000 slides processed per year) laboratories (OR = 1.60, 95% CI 1.22-2.09) and non-squamous histology of cancer increased the odds for a potential false negative result (OR = 3.39, 95% CI 2.37-4.85 for adenocarcinoma, OR = 1.99, 95% CI 1.11-3.55 for other types of carcinoma), whereas cervical ectropion, other macroscopic changes on the cervix and smoking decrease the odds for a potential false negative Pap test result preceding CC (OR = 0.61, 95% CI 0.45-0.82, OR = 0.41, 95% CI 0.25-0.67, OR = 0.60, 95% CI 0.46-0.78, respectively). Proper triage of women with microscopic signs of microorganisms in the Pap smear should be reconsidered and cytology should be assessed in laboratories processing over 9000 slides annually to decrease the odds for negative Pap test result in 2 years before CC diagnosis. Information on macroscopic changes on the cervix provided to cytomorphologist may reduce the risk of a potential false negative cytology result.
宫颈癌(CC)发展的风险因素已得到充分研究,但影响潜在假阴性细胞学在浸润性 CC 诊断前的风险的因素尚不清楚。我们旨在根据波兰组织性宫颈癌筛查计划(OCCSP)的数据来探索这些因素。将 2010-2012 年 OCCSP 中采集的 236 万例巴氏涂片与波兰国家癌症登记处合并,以在异常细胞学和 3 年内筛查正常细胞学后识别 CC 病例。在 1460 例浸润性 CC 中,1025 例由异常细胞学结果预测,399 例由正常细胞学结果预测。多变量逻辑分析表明,巴氏涂片中有微生物存在(OR=2.18,95%CI 1.65-2.87),由较小的实验室(每年处理少于 9000 个载玻片)评估(OR=1.60,95%CI 1.22-2.09)和癌症的非鳞状组织学增加了潜在假阴性结果的几率(OR=3.39,95%CI 2.37-4.85 用于腺癌,OR=1.99,95%CI 1.11-3.55 用于其他类型的癌),而宫颈外翻、宫颈的其他宏观变化和吸烟则降低了潜在假阴性巴氏涂片结果在 CC 之前的几率(OR=0.61,95%CI 0.45-0.82,OR=0.41,95%CI 0.25-0.67,OR=0.60,95%CI 0.46-0.78,分别)。应重新考虑对巴氏涂片有微生物镜下征象的妇女进行适当的分流,并且应在每年处理超过 9000 个载玻片的实验室中评估细胞学,以降低在 CC 诊断前 2 年内阴性巴氏涂片结果的几率。向细胞学形态学家提供宫颈宏观变化的信息可能会降低潜在假阴性细胞学结果的风险。